# OLMESARTAN MEDOXOMIL
> **ANDA203281** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2017-05-25
## Drug
- **FDA Application Number:** ANDA203281
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL
- **Generic name:** OLMESARTAN MEDOXOMIL
- **Active ingredients:** OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2017-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203281)
---
*AI Analytics · CC0 1.0*